Riskpilot← Back to searchSign inGet full accessK/S APOTEKERGADE 9. HADERSLEV
K/SActiveCVR 20738006Uraniavej 14, st.Rental and operating of own or leased real estate · NACE 6820Est. 19971 employees
Revenue 2024
DKK 404K
-20% vs 2023
EBITDA margin
-24.5%
-172% vs 2023
Equity ratio
37.6%
Financial strength
Net profit 2024
DKK -213K
-497% vs 2023
| Revenue | DKK 404K | -20% |
| EBITDA | DKK -99K | -172% |
| Net profit | DKK -213K | -497% |
| Total assets | DKK 6,7M | -3% |
| Equity | DKK 2,5M | +1% |
| Employees | 1 | — |
Legal name
K/S APOTEKERGADE 9. HADERSLEV
CVR number
20738006
Legal form
Kommanditselskab
NACE code
6820 · Rental and operating of own or leased real estate
Founded
10. september 1997
Share capital
—
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af komplementaren alene.
Company purpose
Selskabets formål er at erhverve, eje og udleje fast ejendom.
Address
Uraniavej 14, st.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 576 | 481 | 470 | 564 | 495 | 499 | 544 | 543 | 594 | 592 | 594 | 506 | 404 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -77 |
| EBITDA | 65 | 43 | 232 | 367 | 282 | 319 | 391 | 295 | 321 | 341 | -681 | 138 | -99 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 65 | 43 | 232 | 367 | 282 | 319 | 391 | 295 | 321 | 341 | -681 | 138 | -99 |
| Net financials | -348 | -342 | -337 | -304 | -294 | -152 | -124 | -110 | -105 | -86 | -86 | -174 | -114 |
| Profit before tax | -284 | -300 | -105 | 62 | -12 | 167 | 267 | 186 | 216 | 255 | -767 | -36 | -213 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -284 | -300 | -105 | 62 | -12 | 167 | 267 | 186 | 216 | 255 | -767 | -36 | -213 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 8.000 | 7.711 | 7.728 | 7.780 | 7.836 | 7.870 | 7.850 | 7.797 | 7.793 | 7.870 | 7.013 | 6.928 | 6.742 |
| Equity | 761 | 911 | 1.256 | 2.025 | 2.214 | 2.380 | 2.647 | 2.833 | 3.048 | 3.304 | 2.537 | 2.501 | 2.538 |
| Long-term debt | 6.288 | 6.116 | 6.099 | 5.677 | 5.406 | 5.173 | 4.902 | 4.677 | 4.448 | 4.259 | 4.032 | 3.735 | 3.495 |
| Short-term debt | 951 | 684 | 373 | 78 | 217 | 316 | 301 | 287 | 296 | 308 | 444 | 692 | 709 |
| Total debt | 7.239 | 6.800 | 6.472 | 5.755 | 5.622 | 5.489 | 5.203 | 4.964 | 4.745 | 4.566 | 4.476 | 4.427 | 4.204 |
EBITDA margin
-24.5%
This company
15.8%
Market median
-255% vs market
20122024
Equity ratio
37.6%
This company
38.2%
Market median
+2% vs market
20122024
Return on equity
-8.4%
This company
18.4%
Market median
-146% vs market
20122024
Net profit margin
-52.7%
This company
8.1%
Market median
-751% vs market
20122024
Asset turnover
0.06×
This company
1.12×
Market median
-95% vs market
20122024
Debt / equity
1.66×
This company
0.62×
Market median
-168% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 1998 | — | — | |
| Chairman | 1997 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 25.0% | 25.0% | 2012 | |
| Individual | 20.0% | 20.0% | 1997 | |
| Individual | 20.0% | 20.0% | 2025 | |
| Individual | 20.0% | 20.0% | 1997 | |
| Individual | 20.0% | 20.0% | 1997 | |
| Individual | 10.0% | 10.0% | 2012 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of K/S APOTEKERGADE 9. HADERSLEV also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Christensen | Board of Directors | 0 companies |
| Stig Jessen | Chairman | 0 companies |